Skip to main content
Discover what's not being covered

Utah Approves Nolla Health AI to Issue Acne Prescriptions

Utah, US

Alfred Diaz Evangelista/Pexels

Alfred Diaz Evangelista/Pexels

What Happened

Utah’s Office of AI Policy authorized Nolla Health’s Nolla Derm to autonomously prescribe topical acne treatments to eligible adults in a one‑year pilot—the first U.S. approval for AI initial prescribing. Oversight is phased: two physicians must approve the first 100; next 400 reviewed weekly; physicians audit 10% monthly.

What Happened

Utah’s Office of AI Policy authorized Nolla Health’s Nolla Derm to autonomously prescribe topical acne treatments to eligible adults in a one‑year pilot—the first U.S. approval for AI initial prescribing. Oversight is phased: two physicians must approve the first 100; next 400 reviewed weekly; physicians audit 10% monthly.

Where Sources Agree

  • arrows_inputPhased Oversight Protocol: Some coverage highlights the pilot’s three-stage oversight process as a phased safety protocol, requiring physician approval for the first 100 prescriptions, retrospective weekly review for the next 400 patients, and a 10% monthly audit thereafter, according to official sources.
  • arrows_inputFirst AI Prescription Pilot: Multiple accounts detail that Utah has authorized a 12-month pilot program allowing Nolla Health's AI to issue initial prescriptions for mild-to-moderate acne, according to the Utah Office of Artificial Intelligence Policy.

Where Sources Disagree

  • arrows_outputCharacterization of AI Medical Role: Some reports characterize Nolla Health’s pilot as replacing doctors with autonomous AI to issue prescriptions. In contrast, other sources emphasize that the system complements physicians, operating within a framework of staged human oversight and review.
  • arrows_outputPhysician Oversight Requirements: Reports differ on the level of physician oversight required for the pilot's first 100 patients; some sources specify that two physicians must independently approve each prescription, while others state that a single physician reviews these prescriptions before they are issued.

Timeline

October 5, 2026

Scope, safeguards and backlash: The program is limited to topical acne treatments for mild‑to‑moderate cases with malpractice insurance, 'duty of care' contract provisions, and predefined treatment pathways, but drew pushback from the Utah Medical Licensing Board and scrutiny rooted in earlier Doctronic controversy.

October 5, 2026

Three-stage oversight rollout: The pilot phases in autonomy: the first 100 prescriptions require physician sign‑off, the next 400 are sent to pharmacies and reviewed retrospectively (weekly), and after 500 patients physicians will audit at least 10% of prescriptions monthly.

October 5, 2026

Nolla Derm app launches pilot: The Nolla Derm app went live for eligible Utah adults, charging $4.99/month and using five-angle facial scans, a 10–15 minute intake, and an AI-generated 'acne severity score' to recommend medications from eight approved topical treatments.

Summary by Ground AI

Sources

See All 48

A varied selection of sources chosen by Ground to reflect the diversity of this story’s coverage.

View All Sources

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal